✦ LIBER ✦

Anti-CD30 immunotoxins with native and recombinant dianthin 30

✍ Scribed by Andrea Bolognesi; Pier Luigi Tazzari; Guiseppe Legname; Fabiola Olivieri; Daniela Modena; Roberto Conte; Fiorenzo Stirpe

Book ID: 105228278
Publisher: Springer-Verlag
Year: 1995
Tongue: English
Weight: 520 KB
Volume: 40
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01520292

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of a new recombinant anti-CD

Development of a new recombinant anti-CD30 immunotoxin (CD30L-ETA') for the treatment of Hodgkin's lymphoma

✍ S. Barth; B. Matthey; G. Schön; V. Diehl; A. Engert 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 119 KB

T cells engrafted with a recombinant ant

T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30+ cutaneous lymphoma cells

✍ Hombach, A; Muche, J M; Gerken, M; Gellrich, S; Heuser, C; Pohl, C; Sterry, W; A 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB

Ber-H2 (anti-CD30)-saporin immunotoxin:

Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation

✍ Pier Luigi Tazzari; Andrea Bolognesi; Daniela de Totero; Brunangelo Falini; Robe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Isolation of new anti-CD30 scFvs from DN

Isolation of new anti-CD30 scFvs from DNA-immunized mice by phage display and biologic activity of recombinant immunotoxins produced by fusion with truncated pseudomonas exotoxin

✍ Hendrick Rozemuller; Partha S. Chowdhury; Ira Pastan; Robert J. Kreitman 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 223 KB

To target CD30 on Hodgkin's disease and anaplastic large-cell lymphoma, anti-CD30 single-chain antibodies were obtained by DNA immunization of mice with the complete human CD30 cDNA. Spleens were isolated from mice with high anti-CD30 titer, and the RNA was used for the production of an scFv-display

In vivo and in vitro uptake of an anti-C

In vivo and in vitro uptake of an anti-CD30/saporin immunotoxin by rat liver parenchymal and nonparenchymal cells

✍ Maria Giulia Battelli; Laura Buonamici; Andrea Bolognesi; Fiorenzo Stirpe 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 817 KB

A Ber-H2/saporin immunotoxin, consisting of the single-chain ribosome-inactivating protein saporin-S6 and the anti-CD30 monoclonal antibody Ber-H2, gave encouraging results in the treatment of refractory Hodgkin's disease but caused a transient hepatotoxicity. The accumulation of Ber-H2/saporin conj

Inhibition of metalloproteinases enhance

Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin

✍ Hinrich P. Hansen; Bärbel Matthey; Stefan Barth; Tatiana Kisseleva; Thilo Mokros 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB

## Abstract CD30 is selectively expressed on the tumor cells of a variety of malignant disorders of the immune system and can therefore be used as a target for an anti‐CD30 antibody‐based immunotherapy. However, CD30 is cleaved at the cell surface by tumor necrosis factor‐α converting enzyme (TACE)